With the backlash the FDA has sustained this last year, a lot of it related to lack of technology and not being up to par, perhaps this will turn out to be a productive trip. 

Earlier I posted about remote monitoring and how technology could expand and help with monitoring food products, when you stop and think about it we remotely meet and monitor many other things in society, so why not.  When it comes to inspections, why not have the information on the product sent before it is packaged and goes to market.  We just need some new algorithms written and servers put in to place, to do a quality test for compliance, with results being show both at the FDA and at the factor of origin.  Of course, there would still be a requirement for on premise visits too, but this would certainly cut to the chase, so perhaps CMS and the FDA might look into using technology to help all of us out.  Write up some quality control algorithms to meet for each product and set the standards and start transmitting to the server to run queries and disperse alerts as needed.

A bit of well designed business intelligence to make this a safer place could not hurt at a time like this when there is very little monitoring going on at all, as there will always be those trying to beat the system when it comes down to money.  BD

The release touted next week’s planned visit by HHS Secretary Mike Leavitt and FDA Commissioner Andrew von Eschenbach to China for consultations with officials there and for ribbon-cutting on the agency’s new offices in Beijing, Guangzhou and Shanghai.

Both men, it said, will take part in seminars with Chinese authorities on food and drug “policy and governance,” and, nearer the end, “the latest scientific data on the toxicity of melamine on humans.” Melamine is the poisonous chemical that’s been found in Chinese milk.

http://blogs.wsj.com/health/2008/11/14/feds-send-mixed-message-to-china/

Related Reading: 

Business Intelligence for the FDA on the way

FDA to detain food shipments from China – Why not add some technology to the inspection processes?

A Broken Agency – China and the FDA

Medicine is a Low Tech Business - Clinical Studies still done on paper too!
FDA Reform Planned
FDA Head: We're Boosting I.T.
Study Calling For Medical Device Information To Better Serve Patients And Doctors from the FDA
Congress to industry: 'We need your help'
FDA Approvals – will outsourcing and new budgets help?
Chemicals Flow Unchecked From China to US Drug Market
FDA Chief Relents, Asking Congress to Fund More Foreign Inspections

0 comments :

Post a Comment

 
Top
Google Analytics Alternative